Botox Pricing by Area in Korea
Korean clinics price botulinum toxin (보톡스, botokseu — the common term for any botulinum toxin A injection, regardless of brand) in two ways: per area (a fixed rate for a standard treatment zone regardless of exact unit count) or per unit (₩3,000–8,000 per unit depending on brand and clinic tier). Per-area pricing is the standard model at most Gangnam aesthetic clinics and is more predictable for international patients budgeting a trip.
The table below lists standard per-area rates across Seoul clinic tiers. “Units” are approximate — actual dosing varies by anatomy, muscle mass, and injector preference.
| Area | Approx Units | KRW | USD | AUD |
|---|---|---|---|---|
| Forehead | 15–20u | ₩100,000–180,000 | $74–133 | AUD$113–203 |
| Glabella (frown lines) | 20–25u | ₩100,000–180,000 | $74–133 | AUD$113–203 |
| Crow's feet (both sides) | 10–15u per side | ₩100,000–200,000 | $74–148 | AUD$113–226 |
| Bunny lines (nose) | 5–10u | ₩80,000–120,000 | $59–89 | AUD$90–136 |
| Lip flip | 4–6u | ₩50,000–120,000 | $37–89 | AUD$57–136 |
| Masseter jaw slimming (per side) | 25–30u | ₩150,000–400,000 | $111–295 | AUD$170–452 |
| Neck bands (platysmal bands) | 15–25u per side | ₩150,000–300,000 | $111–221 | AUD$170–339 |
| Full face 3-area package (forehead + glabella + crow's feet) | 45–60u total | ₩300,000–600,000 | $221–443 | AUD$339–678 |
Clinics using per-unit pricing become cost-effective for patients needing lower doses (lip flip, bunny lines) and less so for high-dose areas like masseter, where per-area rates often come out lower. Confirm the pricing model at booking — not at the chair.
Korean Brands vs Allergan: Cost Difference
Four botulinum toxin A products dominate Korean clinic formularies: Nabota (나보타, Nabot-a — Daewoong Pharmaceutical), Botulax (보툴락스, Botulakseu — Hugel), Meditoxin/Neuronox (메디톡신 / 뉴로녹스 — Medytox), and Allergan’s Botox (보톡스). All four are approved by Korea’s Ministry of Food and Drug Safety (MFDS) for cosmetic use and are used routinely in Seoul’s aesthetic clinics.
The price gap between Korean brands and Allergan is consistent: Korean products run ₩3,000–6,000 per unit versus ₩5,000–8,000+ per unit for Allergan Botox at the same clinic. On a 50-unit full-face treatment, that difference translates to ₩100,000–250,000 (USD$74–185 / AUD$113–283) — not trivial, but not the primary cost driver either.
Clinical studies comparing Korean botulinum toxin A brands to Allergan Botox at equivalent dosing show comparable onset time, duration, and safety profiles. The practical implication: a skilled injector using Nabota at correct dosing will produce the same result as Allergan Botox. Patients with a strong brand preference can request Allergan at most Gangnam clinics — expect to pay the per-unit premium. The injector’s anatomical knowledge and dosing accuracy is the variable that determines outcome, not the brand on the vial.
Korea vs Home Country Pricing
Three factors set the price gap between Korea and Western markets: lower clinical overhead costs in Korea, a highly competitive Gangnam aesthetic district that drives per-unit pricing down, and the per-area pricing model that eliminates the escalation common in per-unit Western billing.
| Country | 3-Area Treatment | USD Equivalent | AUD Equivalent | GBP Equivalent |
|---|---|---|---|---|
| Korea (Seoul) | ₩300,000–600,000 | USD$221–443 | AUD$339–678 | GBP£174–349 |
| Australia | AUD$600–1,500 | USD$390–975 | AUD$600–1,500 | GBP£299–747 |
| USA | USD$400–900 | USD$400–900 | AUD$616–1,386 | GBP£232–523 |
| UK | GBP£300–700 | USD$516–1,204 | AUD$794–1,854 | GBP£300–700 |
The saving for an Australian patient treating three areas in Korea is AUD$260–820 per visit. For a US patient, USD$180–460. These figures are for Botox alone — the relative saving on a combined surgical-and-Botox trip is larger because travel costs are already absorbed by the surgical procedure.
One limit to note: Botox results last 3–4 months on average. Savings realized in Korea do not carry forward — maintenance injections on return to Australia or the US will be priced at local rates.
Adding Botox to a Surgery Trip
Korean clinics routinely add Botox to surgical consultations and post-operative follow-ups without charging a separate consultation fee for existing surgical patients — confirm this at booking, as it is not universal, but it is common practice at Gangnam clinics that handle international patients.¹
Timing matters. For facial surgery patients (rhinoplasty, double eyelid, jaw contouring), the two workable windows are: (1) pre-operative consultation, typically 1–2 days before surgery, when the face is unswollen and anatomical landmarks are clear; or (2) the day 7–10 post-operative follow-up, once primary oedema (swelling) has resolved enough for accurate assessment. Same-day Botox alongside major facial surgery is not standard — surgical swelling distorts the muscle landmarks that accurate injection depends on.
For patients having non-facial procedures — breast augmentation, liposuction, body contouring — the timing constraint does not apply. Same-day or day-before Botox is clinically reasonable; confirm with your surgeon.
The practical trip structure for an Australian or UK patient: arrive 1–2 days before surgery, schedule Botox at the pre-op consultation, proceed to surgery, and use the day 7–10 follow-up for any touch-up if indicated. Three treatment areas add approximately ₩300,000–600,000 (AUD$339–678) to a trip already costing AUD$8,000–25,000+ for surgery — a marginal addition at incremental travel cost of zero.
Is Botox cheaper in Korea than in Australia?
Yes — significantly. Per-area Botox at Korean clinics runs ₩100,000–250,000 (AUD$110–275). At Australian clinics, the same treatment area costs AUD$200–500, often more in Sydney or Melbourne. For 3 treatment areas (forehead, glabella, crow's feet), Korea total is approximately AUD$330–825 versus AUD$600–1,500 in Australia. The saving scales up for patients combining Botox with surgical procedures — when you're already flying to Korea for rhinoplasty or double eyelid surgery, adding Botox at the pre-op visit is essentially free travel cost.
Are Korean Botox brands safe?
Korean botulinum toxin brands — Nabota (Daewoong), Botulax (Hugel), Meditoxin/Neuronox (Medytox) — are regulated and approved by Korea's Ministry of Food and Drug Safety (MFDS) for cosmetic use. They are not FDA (USA) or TGA (Australia) approved for administration in those countries, but this is a regulatory jurisdiction matter, not a safety issue — you are receiving treatment in Korea where these products are fully licensed. Clinical studies comparing Korean brands to Allergan Botox at equivalent dosing show comparable efficacy and safety profiles. The injector's skill and dosing accuracy matters more than brand selection.
Can I get masseter Botox the same day as plastic surgery in Korea?
Same-day masseter Botox with major facial surgery (rhinoplasty, jaw contouring) is not standard practice — the jaw area will be swollen and assessment is difficult. Standard timing: masseter Botox at the pre-op consultation visit (1–2 days before surgery) or at the post-op day 7–10 follow-up once primary swelling has settled. For non-facial surgery (breast, body procedures), same-day or day-before masseter Botox is more feasible — confirm with your surgeon at consultation.
¹ Korean Society of Plastic and Reconstructive Surgeons (KSPRS; 대한성형외과학회, Daehan Seonghyeong Oegwa Haghoe). Board certification requirements and public registry. [ksprs-registry-training-requirements]; [ksprs-registry-public-verification]. https://www.plasticsurgery.or.kr/